Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Proteomic Analysis Reveals a PLK1-Dependent G2/M Degradation Program and Links PKA-AKAP2 to Cell Cycle Control.

Autor: Mouery RD; Curriculum in Genetics and Molecular Biology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Hsu C; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Bonacci T; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Bolhuis DL; Department of Biochemistry and Biophysics. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Wang X; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Mills CA; UNC Proteomics Core Facility, Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Toomer ED; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Canterbury OG; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Robertson KC; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Branigan TB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA., Brown NG; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA., Herring LE; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; UNC Proteomics Core Facility, Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Emanuele MJ; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.; Department of Pharmacology. The University of North Carolina at Chapel Hill. Chapel Hill, NC 27599, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Oct 12. Date of Electronic Publication: 2023 Oct 12.